{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:00:14Z","timestamp":1792476014132,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ahj.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T12:08:25Z","timestamp":1572264505000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial"],"prefix":"10.1016","volume":"220","author":[{"given":"April","family":"Slee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Saksena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ahj.2019.10.005_bb0005","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.10.005_bb0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jchf.2018.05.005","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"6","author":"Cikes","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"Suppl","key":"10.1016\/j.ahj.2019.10.005_bb0015","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2019.10.005_bb0020","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"New Eng. J. Med"},{"key":"10.1016\/j.ahj.2019.10.005_bb0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation and heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"New Eng J Med"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.005_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10840-018-0425-0","article-title":"Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials","volume":"51","author":"Brice\u00f1o","year":"2018","journal-title":"J Intervent Card Electrophysiol"},{"issue":"12","key":"10.1016\/j.ahj.2019.10.005_bb0035","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.amjcard.2013.08.014","article-title":"Comparison of predictors of heart failure-related hospitalization or death in patients with versus without preserved left ventricular ejection fraction","volume":"112","author":"Mangla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2019.10.005_bb0040","doi-asserted-by":"crossref","unstructured":"Bittner V1, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993 Oct 13;270(14):1702\u20137.","DOI":"10.1001\/jama.1993.03510140062030"},{"key":"10.1016\/j.ahj.2019.10.005_bb0045","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"AFFIRM Investigators","year":"2002","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ahj.2019.10.005_bb0050","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jacc.2011.07.036","article-title":"Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): an assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses","volume":"58","author":"Saksena","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.10.005_bb0055","unstructured":"Packer DL, Mark DM, Robb RA et al: Effect of catheter ablation vs. antiarrhythmic drug therapy on mortality, stroke, bleeding and cardiac arrest in patients with atrial fibrillation. J. Am. Med. Assoc. 2019: doi: 10.1001 \/jama.2019.0693"},{"key":"10.1016\/j.ahj.2019.10.005_bb0060","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1401426","article-title":"Survival in cardiac resynchronization therapy with mild heart failure","volume":"370","author":"Goldenberg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.10.005_bb0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ejhf.281","article-title":"Early intervention and long-term outcome with cardiac resynchronization therapy in patients without a history of advanced heart failure symptoms","volume":"9","author":"Herscovici","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ahj.2019.10.005_bb0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ahj.2007.06.045","article-title":"Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias","volume":"154","author":"Saksena","year":"2007","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.005_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10840-011-9601-1","article-title":"Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation","volume":"32","author":"Nagarakanti","year":"2011","journal-title":"J Intervent Card Electrophysiol"},{"key":"10.1016\/j.ahj.2019.10.005_bb0080","unstructured":"Slee A, Saad M, Saksena S:Progression of heart failure differs in patients with atrial fibrillation with rate and rhythm control strategies (abstract). Heart Rhythm, 2019: 16, No. 5, Supplement: S176."},{"key":"10.1016\/j.ahj.2019.10.005_bb0085","first-page":"325","article-title":"Saad M","volume":"55","author":"Slee","year":"2019","journal-title":"Saksena S. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction. Journal of Interventional Cardiac Electrophysiology"},{"issue":"23","key":"10.1016\/j.ahj.2019.10.005_bb0090","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter ablation for atrial fibrillation in congestive heart failure","volume":"351","author":"Hsu","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.10.005_bb0095","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study","volume":"109","author":"The AFFIRM","year":"2004","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319302807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319302807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:58:00Z","timestamp":1762077480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319302807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"alternative-id":["S0002870319302807"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}